CNBX Pharmaceuticals Inc. (CNBX) Change in Acquisitions & Divestments (2019 - 2021)

CNBX Pharmaceuticals (CNBX) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $645968.0 in Q1 2021.

• Quarterly Change in Acquisitions & Divestments rose 178.31% year-over-year to $645968.0 in Q1 2021, while the trailing twelve-month figure through Nov 2021 was $645968.0 (changed N/A YoY) and the FY2023 annual result came in at $24702.0, changed N/A from the prior year.
• Change in Acquisitions & Divestments rose to $645968.0 in Q1 2021, from -$824849.0 in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $824849.0 in Q4 2019 to a low of -$824849.0 in Q1 2020.
• A 3-year average of $215322.7 and a median of $645968.0 in 2021 frame the typical range for Change in Acquisitions & Divestments.
• The widest YoY moves for Change in Acquisitions & Divestments: up 178.31% in 2021, down 178.31% in 2021.
• Tracing CNBX's Change in Acquisitions & Divestments over 3 years: stood at $824849.0 in 2019, then slumped by 200.0% to -$824849.0 in 2020, then surged by 178.31% to $645968.0 in 2021.
• The last three Change in Acquisitions & Divestments figures came in at $645968.0 (Q1 2021), -$824849.0 (Q1 2020), and $824849.0 (Q4 2019), per Business Quant data.